Nonoperative treatment of superior labrum anterior posterior tears: improvements in pain, function, and quality of life
STING-mediated intestinal barrier dysfunction contributes to lethal sepsis
The readout for the phase 3 trial of Ziltivekimab is expected in June 2026 if it works, and if its safe, it could establish IL6 inhibition as a new standard of care for cardiovascular risk reduction in chronic kidney disease
Whether you are looking to support your liver, boost your immunity, or simply age more gracefully, the Energy Supplements collection and our All About Liposomes guide can help you take the next step
The Journal of Pharmacology and Experimental Therapeutics has retracted this article. In September 2024, Athira Pharmas LIFT-AD trial of fosgonimetona clinical derivative of Dihexafailed to meet primary and secondary endpoints in 312 mild-to-moderate Alzheimers patients